Case Report
was unremarkable. Complete blood workup was done which showed hemoglobin 15 mg/dl, total count 4700/cmm, differential count -polymorphs: 65%, lymphocytes: 30%, and eosinophils: 5%, and serum creatinine of 1.4 mg/dl. There are no active sediments in urine microscopy and no growth in urine culture. Blood tacrolimus level was 5.6 ng/ml. Cerebrospinal fluid (CSF) analysis was negative for acid-fast bacilli, gram stain, and malignancy [ Table 1 ]. The patient underwent computed tomography brain which was found to be normal; however, magnetic resonance imaging (MRI) with venography revealed acute lacunar infarct in the posterior limb of right internal capsule. The patient developed altered behavior with irrelevant speech. An aim to identify the etiology provoked us to do India ink staining and culture of CSF on Sabouraud agar. India ink demonstrated round encapsulated yeast [ Figure 1 ], and Sabouraud agar showed cream-colored colonies [ Figure 2 ] which confirmed the diagnosis of cryptococcal meningoencephalitis. After withholding the mycophenolate mofetil and dose reduction of the immunosuppressants, namely, tacrolimus tablets 6 mg/day to 1.5 mg/day and prednisolone tablets 10 mg/ day to 5 mg/day, the patient was managed appropriately with lipid emulsion amphotericin B for 6 weeks initially and maintenance treatment of fluconazole tablets 300 mg/ day. With treatment, the patient's left upper and lower limb weakness improved partially. He had mild graft dysfunction with serum creatinine of 2.6 after completion of 6 weeks of treatment probably due to amphotericin B toxicity. Subsequently, the patient's graft function gradually worsened 6 months later probably due to chronic allograft injury. The patient did not consent for graft renal biopsy, and hence, the cause of graft loss could not be ascertained. He was initiated on hemodialysis, which he is continuing on weekly twice schedule.
disCussion
Cryptococcus is basidiomycetes, encapsulated yeast, and has four serotypes. It is transmitted by inhalation or ingestion which remains latent for years until cell-mediated immunity falls. [2] The risk factors of cryptococcal infection are acquired immunodeficiency syndrome, prolonged treatment with glucocorticoids, solid organ transplantation, malignancy, and sarcoidosis.
CNS predilection can be explained by multiple hypotheses; however, the lack of complementary factors in CSF is a major contributing factor. [3] It presents as subacute meningoencephalitis which develops over 2-4 weeks and gets complicated later by hydrocephalus. Cryptococcoma formation is an uncommon presentation which may give rise to symptoms such as seizures, altered sensorium, and focal neurological deficits. [4] A less common presentation is cerebral infarcts secondary to cryptococcal vasculitis. The incidence of infarction secondary to this is variable and occurs in 4%-32% of cases. [5] CSF analysis with Indian ink demonstrates encapsulated yeast in 50% of patients. It is highly specific (97%) but poorly sensitive test (83%). [6] MRI is the investigation of choice which shows miliary enhancing parenchymal nodules, leptomeningeal-cisternal nodules, cryptococcoma, and gelatinous pseudocyst. [7] Antigen testing is the rapid way of diagnosis with high sensitivity and specificity. The poor prognostic indicators are India ink positivity of CSF, CSF white blood cell (WBC) count <20/µL, an initial CSF serum cryptococcal antigen titer >1:32, and a high opening pressure on lumbar puncture. [8] This case had two of these poor prognostic factors, namely, India ink positivity of CSF and a low CSF WBC count. Treatment includes an initial phase with intravenous (IV) liposomal amphotericin (3-4 mg/g/day) or IV lipid emulsion amphotericin 5 mg/kg/day with or without flucytosine at a dose of 100 mg/kg/day followed by CSF examination every 2 weeks and continued treatment till CSF is sterile. This is followed by a consolidation phase of treatment with fluconazole dose of 6 mg/kg/day for 8 weeks followed by a maintenance phase of fluconazole at 3 mg/kg/day for 6-12 months. [9] In this case, the patient had a history of headache and hemiparesis without any fever mimicking a usual thrombotic stroke. If not diagnosed with an extra degree of suspicion, appropriate treatment could have been delayed increasing the mortality and morbidity. To the best of our knowledge, this is the first case report of such an occurrence, and thus, it is presented for its rarity.
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